MedTrace Logo

The Effect of the Serratus Block on Pain Control After Breast Surgery

NCT02453516 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-01-13

No results posted yet for this study

Summary

Surgery for breast cancer is associated with significant pain. The serratus nerve block targets the interfascial plane either below or above the serratus muscle, blocking thereby the lateral cutaneous branches of the intercostal nerves. The purpose of this randomized controlled double-blinded study is to see whether the addition of a serratus nerve block to a general anesthesia results in a better postoperative pain control in patients undergoing surgery for breast cancer.

Conditions

  • Anesthesia

Interventions

PROCEDURE

Serratus Block

Ultrasound-guided nerve block using ropivacaine 0.5% (0.4ml/kg) injected between the serratus anterior and external intercostal muscles

PROCEDURE

Placebo Block

Subcutaneous injection of 1ml sterile normal saline solution in the midaxillary line

DRUG

ropivacaine

Drug indicated for regional anesthesia

DRUG

epinephrine

Drug indicated to prolong the action of regional anesthesia

OTHER

sterile saline

Neutral injection (no drug involved)

Sponsors & Collaborators

  • Women's College Hospital

    lead OTHER

Principal Investigators

  • Richard Brull, MD FRCP · Women's College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-29
Primary Completion
2019-09-11
Completion
2019-12-11

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02453516 on ClinicalTrials.gov